Mario Gabelli (NYSE: GRX) Discloses Series G Preferred Share Trades

Rhea-AI Filing Summary

Mario J. Gabelli reported insider transactions in Gabelli Healthcare & WellnessRx Trust Series G Cumulative Preferred Shares. On 12/26/2025, affiliates recorded a purchase of 100,000 Series G shares at $10 per share through GAMCO Investors, Inc., bringing GAMCO’s indirectly held amount to 500,000 shares. On the same date, 500,000 Series G shares were surrendered at $10 per share by Associated Capital Group, Inc. in connection with a right to put up to 100% of the outstanding Series G preferred shares to the fund, after which AC was shown with 1,500,000 shares. The filing notes Gabelli is a director, 10% owner, and control person of the adviser, and that he disclaims beneficial ownership beyond his indirect pecuniary interest in both GAMCO and AC holdings.

SEC Form 4

FORM 4

UNITED STATES SECURITIES AND EXCHANGE COMMISSION
Washington, D.C. 20549

STATEMENT OF CHANGES IN BENEFICIAL OWNERSHIP

Filed pursuant to Section 16(a) of the Securities Exchange Act of 1934
or Section 30(h) of the Investment Company Act of 1940

OMB APPROVAL

OMB Number:			3235-0287
Estimated average burden
hours per response:			0.5

Check this box if no longer subject to Section 16. Form 4 or Form 5 obligations may continue. See Instruction 1(b).

Check this box to indicate that a transaction was made pursuant to a contract, instruction or written plan for the purchase or sale of equity securities of the issuer that is intended to satisfy the affirmative defense conditions of Rule 10b5-1(c). See Instruction 10.

1. Name and Address of Reporting Person^*

GABELLI MARIO J

(Last) (First) (Middle)

C/O GAMCO INVESTORS, INC.

ONE CORPORATE CENTER

(Street)

RYE NY 10580

(City) (State) (Zip)

2. Issuer Name and Ticker or Trading Symbol
Gabelli Healthcare & WellnessRx Trust [ GRX.G ]

5. Relationship of Reporting Person(s) to Issuer
(Check all applicable)

X	Director	X	10% Owner
	Officer (give title below)	X	Other (specify below)
			Control Person of Adviser

3. Date of Earliest Transaction (Month/Day/Year)
12/26/2025

4. If Amendment, Date of Original Filed (Month/Day/Year)

6. Individual or Joint/Group Filing (Check Applicable Line)

X	Form filed by One Reporting Person
	Form filed by More than One Reporting Person

Table I - Non-Derivative Securities Acquired, Disposed of, or Beneficially Owned
1. Title of Security (Instr. 3)	2. Transaction Date (Month/Day/Year)	2A. Deemed Execution Date, if any (Month/Day/Year)	3. Transaction Code (Instr. 8)		4. Securities Acquired (A) or Disposed Of (D) (Instr. 3, 4 and 5)			5. Amount of Securities Beneficially Owned Following Reported Transaction(s) (Instr. 3 and 4)	6. Ownership Form: Direct (D) or Indirect (I) (Instr. 4)	7. Nature of Indirect Beneficial Ownership (Instr. 4)
			Code	V	Amount	(A) or (D)	Price
Series G Cumulative Preferred Shares	12/26/2025		P		100,000	A	$10	500,000	I	GAMCO Investors, Inc.(1)
Series G Cumulative Preferred Shares	12/26/2025		J(2)		500,000	D	$10	1,500,000	I	Associated Capital Group, Inc.(3)
Series G Cumulative Preferred Shares								200,000	D

Table II - Derivative Securities Acquired, Disposed of, or Beneficially Owned (e.g., puts, calls, warrants, options, convertible securities)
1. Title of Derivative Security (Instr. 3)	2. Conversion or Exercise Price of Derivative Security	3. Transaction Date (Month/Day/Year)	3A. Deemed Execution Date, if any (Month/Day/Year)	4. Transaction Code (Instr. 8)		5. Number of Derivative Securities Acquired (A) or Disposed of (D) (Instr. 3, 4 and 5)		6. Date Exercisable and Expiration Date (Month/Day/Year)		7. Title and Amount of Securities Underlying Derivative Security (Instr. 3 and 4)		8. Price of Derivative Security (Instr. 5)	9. Number of derivative Securities Beneficially Owned Following Reported Transaction(s) (Instr. 4)	10. Ownership Form: Direct (D) or Indirect (I) (Instr. 4)	11. Nature of Indirect Beneficial Ownership (Instr. 4)
				Code	V	(A)	(D)	Date Exercisable	Expiration Date	Title	Amount or Number of Shares

Explanation of Responses:

1. The shares reported reflect the total shares owned by GAMCO Investors, Inc. (GAMCO). Mario J. Gabelli is the Chairman, Chief Executive Officer, and controlling shareholder of GAMCO. Mr. Gabelli has less than a 100% interest in GAMCO and disclaims beneficial ownership of the shares held by it which are in excess of his indirect pecuniary interest.

2. Shares were surrendered in accordance with Right to Put to the Fund up to 100% of Outstanding Series G Cumulative Preferred Shares.

3. The shares reported reflect the total shares owned by Associated Capital Group, Inc. (AC). Mario J. Gabelli is the Executive Chair and controlling shareholder of AC. Mr. Gabelli has less than a 100% interest in AC and disclaims beneficial ownership of the shares held by it which are in excess of his indirect pecuniary interest.

	Douglas R. Jamieson as Attorney-in-Fact for Mario J. Gabelli	12/30/2025
	** Signature of Reporting Person	Date
Reminder: Report on a separate line for each class of securities beneficially owned directly or indirectly.
* If the form is filed by more than one reporting person, see Instruction 4 (b)(v).
** Intentional misstatements or omissions of facts constitute Federal Criminal Violations See 18 U.S.C. 1001 and 15 U.S.C. 78ff(a).
Note: File three copies of this Form, one of which must be manually signed. If space is insufficient, see Instruction 6 for procedure.
Persons who respond to the collection of information contained in this form are not required to respond unless the form displays a currently valid OMB Number.

FAQ

What insider transactions did Mario J. Gabelli report for GRX on 12/26/2025?

The filing reports a purchase of 100,000 Series G Cumulative Preferred Shares of Gabelli Healthcare & WellnessRx Trust (GRX) at $10 per share through GAMCO Investors, Inc., and a surrender of 500,000 Series G shares at $10 per share by Associated Capital Group, Inc. under a put right.

How many GRX Series G preferred shares are indirectly owned after the reported transactions?

After the reported transactions, GAMCO Investors, Inc. is shown with 500,000 Series G Cumulative Preferred Shares, and Associated Capital Group, Inc. is shown with 1,500,000 Series G shares, all reported as indirect holdings for Mario J. Gabelli.

What is the nature of Mario J. Gabellis relationship to Gabelli Healthcare & WellnessRx Trust (GRX)?

The filing identifies Mario J. Gabelli as a director, a 10% owner, and a control person of the adviser to Gabelli Healthcare & WellnessRx Trust.

What does the put right mentioned in the GRX Form 4 involve?

The explanation states that 500,000 Series G Cumulative Preferred Shares were surrendered in accordance with a Right to Put to the Fund up to 100% of Outstanding Series G Cumulative Preferred Shares.

How does Mario J. Gabelli describe his beneficial ownership of GAMCO and AC GRX shares?

The filing explains that Mario J. Gabelli is the controlling shareholder of both GAMCO Investors, Inc. and Associated Capital Group, Inc. but has less than a 100% interest in each and disclaims beneficial ownership of shares held by them that exceed his indirect pecuniary interest.

Were the GRX insider transactions reported as direct or indirect holdings?

All reported positions in the Series G Cumulative Preferred Shares are listed as indirect holdings, attributed through GAMCO Investors, Inc. and Associated Capital Group, Inc. rather than as directly owned by Mario J. Gabelli.